For quarters beginning on and after January 1, 2020, CMS will require Responsible Reporting Entities (RREs) to include information on prescription drugs in their Section 111 quarterly reporting.
091019 California Relaxes Registration Requirements for Opposite-Sex Domestic Partners
In a bipartisan effort, the U.S. Congress agreed on a spending package to fund the federal government which included important changes to federal laws affecting employer-sponsored group health and
While many states have enacted their own legislation surrounding the coronavirus disease 2019 (COVID-19), the federal government has begun releasing guidance and proposed legislation with respect to
All multiple employer welfare arrangements (MEWAs) must file Form M-1 with the DOL by Friday, March 1, 2019 (unless an extension is requested).
Although the severity and extent of the COVID-19 pandemic has been unprecedented in modern times, there are safeguards built into the structure of the insurance industry that are designed to maintain
Specialty drugs are expensive medications that are used to treat complex, chronic medical conditions. They are often given by injection or infusion and are potential life savers for patients
Recently, the term “transparency in healthcare” has been mentioned during discussions focusing on our nation’s healthcare system and ensuing conversation often centers on how the lack of transparency
The IRS has announced that amounts paid for certain personal protective equipment used to prevent the spread of COVID-19, including masks, hand sanitizer and sanitizing wipes can be treated as
Due to the ongoing COVID-19 public health crisis, the requirement for employers to submit the 2020 Annual Reporting Form for the San Francisco Health Care Security Ordinance (HCSO) and the Fair
Our Advisors offer in-depth analysis and are ready to help you successfully navigate employee benefits and health insurance.
Our website uses cookies. Click here to view our privacy policy.